NCT07041385 - Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women | Biotech Hunter

Enrollment

340

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Preeclampsia (PE)

Interventions

DRUG

Aspirin 75 mg

"This study aims to evaluate the effectiveness of 75 mg aspirin versus 150 mg aspirin in preventing preeclampsia among individuals with high risk for the condition.~Eligible women attending the antenatal clinic were screened by history, physical exam, and uterine artery Doppler. Risk assessment was entered into the Fetal Medicine Foundation software. Participants were randomized:~Group A: 75 mg aspirin nightly. Group B: 150 mg aspirin nightly."

DRUG

Aspirin 150 mg

"This study aims to evaluate the effectiveness of 75 mg aspirin versus 150 mg aspirin in preventing preeclampsia among individuals with high risk for the condition.~Eligible women attending the antenatal clinic were screened by history, physical exam, and uterine artery Doppler. Risk assessment was entered into the Fetal Medicine Foundation software. Participants were randomized:~Group A: 75 mg aspirin nightly. Group B: 150 mg aspirin nightly."

Trial Locations (1)

54000

Shalamar Hospital, Lahore